Chronic Myeloid Leukemia | Topics

Study Finds Treatment-Free Remission Not Impaired by Low-Dose TKIs for Patients with CML
September 09, 2020

Researchers found that long-term treatment-free remission was not impaired by low-dose TKI regimens for patients with chronic myeloid leukemia.

Phase 3 ASCEMBL Study Meets Primary End Point In Patients with CML
August 26, 2020

The study is evaluating asciminib in adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase who were previously treated with 2 or more tyrosine-kinase inhibitors.

FDA Grants Orphan Drug Designation to HQP1351 for Chronic Myeloid Leukemia
May 05, 2020

The FDA granted orphan drug designation to Ascentage Pharma’s HQP1351 for the treatment of chronic myeloid leukemia.